Back
Eaton Vance Tax-Managed Buy-Write Income Fund Vs. Novo Nordisk AS Industry Stock Comparison
Buy
73
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund
Last Price:
$15.11
Seasonality Move:
-0.02%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.40
Seasonality Move:
6.58%
Buy
73
Eaton Vance Tax-Managed Buy-Write Income Fund (ETB)
is a Buy
Is Eaton Vance Tax-Managed Buy-Write Income Fund a Buy, Sell or Hold?
-
The current Eaton Vance Tax-Managed Buy-Write Income Fund [ETB] share price is $15.05. The Score for ETB is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
ETB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ETB Stock Price Chart
What is Eaton Vance Tax-Managed Buy-Write Income Fund's stock price today?
-
The Eaton Vance Tax-Managed Buy-Write Income Fund share price today is $15.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ETB is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ETB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 55.45 | Buy |
Chaikin Money Flow: | 78649 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.89 - 15.11) | Buy |
Bollinger Bands (100): | (14.02 - 14.86) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | 14079249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.16 - 111.42) | Sell |
Bollinger Bands (100): | (106.53 - 131.27) | Sell |
ETB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.03 | Buy |
20-day SMA: | 15.04 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 14.09 | Buy |
8-day EMA: | 15.01 | Buy |
20-day EMA: | 14.99 | Buy |
50-day EMA: | 14.8 | Buy |
200-day EMA: | 14.2 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.84 | Sell |
20-day SMA: | 105.84 | Sell |
50-day SMA: | 108.65 | Sell |
200-day SMA: | 126.03 | Sell |
8-day EMA: | 99.1 | Sell |
20-day EMA: | 103.93 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.8 | Sell |
Eaton Vance Tax-Managed Buy-Write Income Fund Earnings Growth & ETB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
Eaton Vance Tax-Managed Buy-Write Income Fund Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |